Shares of Regeneron Pharmaceuticals Inc. REGN, +0.02% inched 0.02% higher to $840.81 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +1.10% rising 1.10% to 4,436.01 and the Dow Jones Industrial Average DJIA, +0.54% rising 0.54% to 34,472.98.
Regeneron Pharmaceuticals Inc. closed $6.69 below its 52-week high ($847.50), which the company reached on August 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. AMGN, -0.10% fell 0.10% to $257.36, Moderna Inc. MRNA, -0.67% fell 0.67% to $115.46, and Gilead Sciences Inc. GILD, +0.90% rose 0.90% to $77.04.
Trading volume (539,477) remained 128,972 below its 50-day average volume of 668,449.